FLGT
Fulgent Genetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$20.10
+1.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.55x
- Price / sales
- 1.71x
- Price / cash flow
- -6.61x
Enterprise value
- Enterprise value
- $299.8M
- EV / sales
- 0.93x
- EV / EBITDA
- -4.61x
- EV / EBIT
- -2.50x
- Market cap
- $553.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026